L11 Valuing and Evaluating Assets Flashcards Preview

Biotechnology in Practice > L11 Valuing and Evaluating Assets > Flashcards

Flashcards in L11 Valuing and Evaluating Assets Deck (22)
Loading flashcards...
1
Q

Evaluation vs Valuation

A

Evaluation:
- considers all aspects of a business excluding its monetary value

Valuation:

  • calculation of the monetary worth of a business or an asset
  • a valuation can be used to support an investment decision
2
Q

What can be decided from an evaluation?

A

an evaluation can be used to determine the validity of a business plan or a revenue model with a view to discontinuing or modifying a business plan (or corporate structure)

An evaluation may be used to partly support an investment decision

3
Q

Classification

A

Classification, or grouping companies by attributes or common features provides a basis for:

  • creating and applying relevant measures of performance
  • comparison of business plans, strategies, structures
  • competitor analysis
4
Q

Categories of classification

A

see onenote

  1. age/maturity profile
  2. broad sector
  3. regulatory pathway
  4. revenue model
  5. technology
  6. specification of use
  7. corporate status and focus
  8. sales model
  9. sales frequency and price (value)
  10. product use frequency
5
Q

Classification flow diagram

A

see onenote

6
Q

What needs to be assessed - Reward

A

Reward requires the examination of:

  • market opportunity according to addressable, accessible, value and contestable markets (by value and unit sales, by frequency of transactions)
  • drivers of demand (demographics, customer needs)
  • acquisition potential (demand for business, income streams, new customers, partially developed assets or patents)
7
Q

Addressable

A

the total pool of customers (patients) who could benefit from a product

8
Q

Accessible

A

the pool of customers (patients) who can pay for a product or be reimbursed

9
Q

Value

A

the market defined by sales actually achieved

10
Q

Contestable

A

the pool of customers (patients) who have, directly or indirectly, the ability to switch between existing and new products

11
Q

Contestability determined by:

A
  1. number of existing products or services
  2. entrenchment of existing products and brands
  3. degree of benefit/s of newer products
  4. number and size of existing firms
  5. entrenchment of industrial base (status quo)
  6. degree of learning required
  7. resistance of opinion followers
  8. proximity of displacement or enabling technologies
  9. queue factors (order of place, num. members)
12
Q

What needs to be assessed - risk

A

see onenote slides and side notes

  1. capabilities
  2. capital resources
  3. staffing
  4. performance history
  5. business plan
  6. competitiveness
  7. IP
  8. manufacturing
  9. competitor intensity
  10. presence or influence of orthodox values, structures and guidelines
  11. corporate structure
  12. owners of the business
  13. corporate domicile and laws governing the operations of the firm
  14. territorial considerations
  15. governance
  16. communication capabilities
  17. commitments, obligations and liabilities
  18. time
13
Q

Information Sources

A

see onenote slides

14
Q

Limitations

A
  • the problem of confidentiality
  • information asymmetry
  • information overload
  • making and using estimates - the need to approximate
15
Q

Some considerations

A
  • management pride and bias
  • management misrepresentation
  • maintaining objectivity
16
Q

Writing an evaluation report

A

see onenote

17
Q

Classifications, Valuation Methods Overlay flow diagram

A

see onenote

18
Q

Price/Earnings Ratio

A

see onenote

  • the ratio of a company’s share price to its earnings (net profit after tax) and it is equivalent to the capitalisation of the company (number of shares on issue multiplied by its share price) divided by its net profit after tax (NPAT)
  • describes how many years of earning it would take to cover the share price i.e. to pay it back

A high PE of 30 in effect means 30 years twice as long as a PE of 15 HOWEVER high PEs usually signal higher sales growth, which implies a shorter payback period

19
Q

Price/Sales Ratio

A

see onenote

  • the ratio of a company’s share price to its sales per share and it is equivalent the capitalisation of a company divided by its sales

PS Ratio can be used to compare a company with traded shares with any other listed company

20
Q

Asset Valuation - a simplified example

A

see onenote slides

21
Q

pNPV modelling

A

see onenote

NPV = net present value

The influence of risk on an asset under development can be explored in a probability adjusted NPV model

22
Q

Conclusions

A

The evaluation process can lead to the discovery of weaknesses, unaddressed risks and new unknowns; such results be used by business owners and managers to improve the business, help investors review investments or uncover and rank new investment prospects

a valuation can support the investment process by providing a range of estimates of monetary worth